High prevalence of central nervous system medications in community-dwelling older adults with dementia over a three-year period

D. Fick, A. Kolanowski, Jennifer L Waller

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

Few recent studies have investigated the prevalence and outcomes for central nervous system (CNS)-active medication use in older persons with dementia (PWD) who live in the community. Thus, the purpose of this study was to describe the health outcomes and patterns of use of CNS-active drugs in PWD living in the community. Using a retrospective study design from a southeastern managed care organization (MCO), claims data were collected for three years on all identified cases with dementia and included age, gender, medical diagnoses for each claim (International Classification of Disease [ICD-9 code]) and prescription drugs (National Drug Code [NDC]). Individuals (N = 960) were selected who were continuously enrolled and had prescription drug coverage. Over 79% of PWD in this sample were on a CNS-active medication during the three-year period and 35% were on a benzodiazepine. The highest number of drug-related problems (DRPs) within 45 days after receiving a CNS drug prescription were for syncope, fatigue, altered level of consciousness, delirium, constipation, falls and fractures. This study illustrates the need to further examine inappropriate CNS-active medication use in PWD and to test non-pharmacologic therapies for the clinical problems that initiate their use in PWD.

Original languageEnglish (US)
Pages (from-to)588-595
Number of pages8
JournalAging and Mental Health
Volume11
Issue number5
DOIs
StatePublished - Sep 1 2007

Fingerprint

Independent Living
Dementia
Central Nervous System
International Classification of Diseases
Central Nervous System Agents
Prescription Drugs
Consciousness Disorders
Drug Prescriptions
Delirium
Syncope
Managed Care Programs
Constipation
Benzodiazepines
Pharmaceutical Preparations
Fatigue
Retrospective Studies
Organizations
Health

ASJC Scopus subject areas

  • Phychiatric Mental Health
  • Gerontology
  • Geriatrics and Gerontology
  • Psychiatry and Mental health

Cite this

High prevalence of central nervous system medications in community-dwelling older adults with dementia over a three-year period. / Fick, D.; Kolanowski, A.; Waller, Jennifer L.

In: Aging and Mental Health, Vol. 11, No. 5, 01.09.2007, p. 588-595.

Research output: Contribution to journalArticle

@article{7a0200e2355e4dc4a9d56c03e59f3893,
title = "High prevalence of central nervous system medications in community-dwelling older adults with dementia over a three-year period",
abstract = "Few recent studies have investigated the prevalence and outcomes for central nervous system (CNS)-active medication use in older persons with dementia (PWD) who live in the community. Thus, the purpose of this study was to describe the health outcomes and patterns of use of CNS-active drugs in PWD living in the community. Using a retrospective study design from a southeastern managed care organization (MCO), claims data were collected for three years on all identified cases with dementia and included age, gender, medical diagnoses for each claim (International Classification of Disease [ICD-9 code]) and prescription drugs (National Drug Code [NDC]). Individuals (N = 960) were selected who were continuously enrolled and had prescription drug coverage. Over 79{\%} of PWD in this sample were on a CNS-active medication during the three-year period and 35{\%} were on a benzodiazepine. The highest number of drug-related problems (DRPs) within 45 days after receiving a CNS drug prescription were for syncope, fatigue, altered level of consciousness, delirium, constipation, falls and fractures. This study illustrates the need to further examine inappropriate CNS-active medication use in PWD and to test non-pharmacologic therapies for the clinical problems that initiate their use in PWD.",
author = "D. Fick and A. Kolanowski and Waller, {Jennifer L}",
year = "2007",
month = "9",
day = "1",
doi = "10.1080/13607860601086629",
language = "English (US)",
volume = "11",
pages = "588--595",
journal = "Aging and Mental Health",
issn = "1360-7863",
publisher = "Taylor and Francis Ltd.",
number = "5",

}

TY - JOUR

T1 - High prevalence of central nervous system medications in community-dwelling older adults with dementia over a three-year period

AU - Fick, D.

AU - Kolanowski, A.

AU - Waller, Jennifer L

PY - 2007/9/1

Y1 - 2007/9/1

N2 - Few recent studies have investigated the prevalence and outcomes for central nervous system (CNS)-active medication use in older persons with dementia (PWD) who live in the community. Thus, the purpose of this study was to describe the health outcomes and patterns of use of CNS-active drugs in PWD living in the community. Using a retrospective study design from a southeastern managed care organization (MCO), claims data were collected for three years on all identified cases with dementia and included age, gender, medical diagnoses for each claim (International Classification of Disease [ICD-9 code]) and prescription drugs (National Drug Code [NDC]). Individuals (N = 960) were selected who were continuously enrolled and had prescription drug coverage. Over 79% of PWD in this sample were on a CNS-active medication during the three-year period and 35% were on a benzodiazepine. The highest number of drug-related problems (DRPs) within 45 days after receiving a CNS drug prescription were for syncope, fatigue, altered level of consciousness, delirium, constipation, falls and fractures. This study illustrates the need to further examine inappropriate CNS-active medication use in PWD and to test non-pharmacologic therapies for the clinical problems that initiate their use in PWD.

AB - Few recent studies have investigated the prevalence and outcomes for central nervous system (CNS)-active medication use in older persons with dementia (PWD) who live in the community. Thus, the purpose of this study was to describe the health outcomes and patterns of use of CNS-active drugs in PWD living in the community. Using a retrospective study design from a southeastern managed care organization (MCO), claims data were collected for three years on all identified cases with dementia and included age, gender, medical diagnoses for each claim (International Classification of Disease [ICD-9 code]) and prescription drugs (National Drug Code [NDC]). Individuals (N = 960) were selected who were continuously enrolled and had prescription drug coverage. Over 79% of PWD in this sample were on a CNS-active medication during the three-year period and 35% were on a benzodiazepine. The highest number of drug-related problems (DRPs) within 45 days after receiving a CNS drug prescription were for syncope, fatigue, altered level of consciousness, delirium, constipation, falls and fractures. This study illustrates the need to further examine inappropriate CNS-active medication use in PWD and to test non-pharmacologic therapies for the clinical problems that initiate their use in PWD.

UR - http://www.scopus.com/inward/record.url?scp=34548833601&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34548833601&partnerID=8YFLogxK

U2 - 10.1080/13607860601086629

DO - 10.1080/13607860601086629

M3 - Article

C2 - 17882597

AN - SCOPUS:34548833601

VL - 11

SP - 588

EP - 595

JO - Aging and Mental Health

JF - Aging and Mental Health

SN - 1360-7863

IS - 5

ER -